Ultragenyx Pharmaceutical Inc’s filing revealed that its EVP and Chief Medical Officer Crombez Eric unloaded Company’s shares for reported $20405.0 on May 05 ’25. In the deal valued at $39.24 per share,520 shares were sold. As a result of this transaction, Crombez Eric now holds 71,530 shares worth roughly $2.51 million.
Then, Crombez Eric sold 242 shares, generating $8,497 in total proceeds. Upon selling the shares at $35.11, the EVP and Chief Medical Officer now owns 71,680 shares.
Before that, Horn Howard sold 1,785 shares. Ultragenyx Pharmaceutical Inc shares valued at $72,114 were divested by the Chief Financial Officer at a price of $40.40 per share. As a result of the transaction, Horn Howard now holds 106,169 shares, worth roughly $3.72 million.
Goldman upgraded its Ultragenyx Pharmaceutical Inc [RARE] rating to a Buy from a a Neutral in a research note published on June 06, 2024; the price target was increased to $67 from $56. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. Wells Fargo began covering RARE with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of RARE
On Tuesday, Ultragenyx Pharmaceutical Inc [NASDAQ:RARE] saw its stock fall -1.63% to $35.08. Over the last five days, the stock has lost -3.07%. Ultragenyx Pharmaceutical Inc shares have fallen nearly -16.62% since the year began. Nevertheless, the stocks have fallen -14.61% over the past one year. While a 52-week high of $60.37 was reached on 02/06/25, a 52-week low of $29.59 was recorded on 04/09/25. SMA at 50 days reached $36.31, while 200 days put it at $45.61.
Levels Of Support And Resistance For RARE Stock
The 24-hour chart illustrates a support level at 34.60, which if violated will result in even more drops to 34.12. On the upside, there is a resistance level at 35.89. A further resistance level may holdings at 36.70. The Relative Strength Index (RSI) on the 14-day chart is 45.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.57%. Stochastics %K at 50.48% indicates the stock is a holding.
